The Application of Deep Learning in Medicine: Benefits, Challenges, and Future Prospects

Olja Krčadinac; Nebojša Stojaković

doi:10.18485/juuntics240101019s

Authors

Olja Krčadinac University “Union – Nikola Tesla”, Faculty of Informatics and Computer Science, Belgrade, Serbia Author https://orcid.org/0000-0002-6299-371X
Nebojša Stojaković University “Union – Nikola Tesla”, Faculty of Informatics and Computer Science, Belgrade, Serbia Author https://orcid.org/0009-0004-4772-0045

DOI:

https://doi.org/10.18485/juuntics240101019s

Keywords:

Artificial Intelligence (AI), Deep Learning, Disease Prediction, Healthcare

Abstract

Deep learning has emerged as a transformative technology in the field of medicine, offering numerous advantages in the diagnosis, treatment, and management of healthcare. This paper explores the application of deep learning in medicine, highlighting its benefits, challenges, and future prospects. The advantages of deep learning include enhanced accuracy and efficiency in diagnosing medical conditions, automation of administrative tasks, support for personalized and preventive care, and the potential for early disease detection and improved treatment outcomes. However, the use of deep learning in healthcare also presents several challenges, including issues related to data transparency, bias in datasets, integration with existing healthcare systems, and the need for high-quality data. Furthermore, the technology's dependence on specialized expertise and the significant costs associated with its implementation pose additional barriers to widespread adoption. Despite these challenges, the future of deep learning in medicine holds great promise, with potential advancements in clinical decision-making, drug discovery, and healthcare accessibility, particularly in underserved and remote areas. This paper provides an overview of the current state of deep learning in medicine and discusses its implications for the future of healthcare.

Downloads

Download data is not yet available.

References

Alowais, S., Alghamdi, S., Alsuhebany, N., Alqahtani, T., Alshaya, A., Almohareb, S., & Albekairy, A. (2023). Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC medical education, 23(1), 689.

Bhambri, P., & Khang, A. (2024). Managing and Monitoring Patient’s Healthcare Using AI and IoT Technologies. In Driving Smart Medical Diagnosis Through AI-Powered Technologies and Applications, IGI Global, 1-23.

Bhattacharya, S., Maddikunta, P., Pham, Q., Gadekallu, T., Chowdhary, C., Alazab, M., & Piran, M. (2021). Deep learning and medical image processing for coronavirus (COVID-19) pandemic: A survey. . Sustainable cities and society, 65, 102589.

Dara, S., Dhamercherla, S., Jadav, S., Babu, C., & Ahsan, M. (2022). Machine learning in drug discovery: a review. Artificial intelligence review, 55(3), 1947-1999.

Hider, M., Nasiruddin, M., & Al Mukaddim, A. (2024). Early Disease Detection through Advanced Machine Learning Techniques: A Comprehensive Analysis and Implementation in Healthcare Systems. Revista de Inteligencia Artificial en Medicina, 15(1), 1010-1042.

Johnson, A., Ghassemi, M., Nemati, S., Niehaus, K., Clifton, D., & Clifford, G. (2016). Machine learning and decision support in critical care. Proceedings of the IEEE, 104(2), 444-466.

Kalusivalingam, A., Sharma, A., Patel, N., & Singh, V. (2021). Leveraging Deep Learning and Random Forest Algorithms for AI-Driven Genomics in Personalized Medicine. International Journal of AI and ML, 2(3).

Li, M., Zhang, Y., & Zhu, H. (2023). Medical image analysis using deep learning algorithms. Frontiers in Public Health, 11, 1273253.

Pepe, M., Etzioni, R., Feng, Z., Potter, J., Thompson, M., Thornquist, M., & Yasui, Y. (2001). Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute, 93(14), 1054-1061.

rabhod, K. (2024). The Role of Artificial Intelligence in Reducing Healthcare Costs and Improving Operational Efficiency. Quarterly Journal of Emerging Technologies and Innovations, 9(2), 47-59.

Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H., Jin, J., Zhou, M., & Zhang, B. (2021). Artificial intelligence and machine learning-ided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Medicinal research reviews, 41(3), 1427-1473.

Zhang, B., Shi, H., & Wang, H. (2023). Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach. Journal of multidisciplinary healthcare, 1779-1791.